Coherus Oncology Inc (CHRS)

Other Income/Expenses (Net)

-$1.02M

Quarterly · Period ending: · USD

CHRS logo

CHRS Other Income/Expenses (Net)

Latest reported-$1.02M
CHRS Quarterly Other Income/Expenses (Net) ($577.00K → -$1.02M)
High-resolution chart · PNG

CHRS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,016,000
-784,000
-467,000
-2,284,000
624,000
-1,963,000
-8,450,000
-4,364,000
7,588,000
-249,000
-10,748,000
-8,015,000
-8,326,000
-7,984,000
-7,377,000
-6,201,000
-6,137,000
-15,159,000
-6,178,000
-5,741,000
-5,736,000
-5,587,000
-5,665,000
-5,600,000
-4,985,000
-4,363,000
-3,762,000
-3,951,000
-3,875,000
-3,405,000
-2,094,000
-1,854,000
1,225,000
-2,270,000
-2,603,000
-2,378,000
1,236,000
-2,405,000
-2,484,000
-773,000
-7,414,000
-1,186,000
-373,000
-268,000
-139,000
-4,091,000
-2,463,000
-1,491,000
-7,132,000
-11,409,000
-4,104,000
-14,690,000
575,000
577,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.